Breast Imaging Market

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Breast Imaging Market by Technology [Mammography (FFDM, Digital & 3D Mammography), Breast Ultrasound, MRI, CBCT, MBI, PET-CT, ABUS, Optical Imaging], End user (Hospitals & Clinics, Breast Care Centers, Diagnostic Imaging Centers) & Region - Global Forecasts to 2025

FREE BROCHURE FREE SAMPLE REPORT

Report Code: MD 2554 Apr, 2020, by marketsandmarkets.com

REQUEST FREE CUSTOMIZATION Inquire Before Buying

Updated on : February 17, 2023

The global breast imaging market in terms of revenue was estimated to be worth $3.6 billion in 2020 and is poised to reach $5.4 billion by 2025, growing at a CAGR of 8.1% from 2020 to 2025. Market growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programsas well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.

Breast Imaging Market

By technology, the non-ionizing breast imaging segment of breast imaging market, is expected to grow at the highest rate during the forecast period

Based on technology, the global market is segmented into ionizing breast imaging and non-ionizing breast imaging technologies. The non-ionizing breast imaging segment is expected to grow at the highest CAGR during the forecast period. Growth inthis segment can be attributed to the advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as greater generation of anatomical details for diagnosis, high sensitivity to small breast lesions in women with dense breast tissues, and fewerfalse positives.

By type, the mammography segment was the largest contributor to the ionizing breast imaging technologies market in 2019

The market for ionizing breast imaging technologies, by type, comprises mammography (analog mammography, full-field digital mammography, and 3D breast tomosynthesis), positron emission tomography-computed tomography (PET-CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), positron emission mammography (PEM), and cone-beam computed tomography (CBCT). Mammography accounted for the largest share of the ionizing breast imaging technologies market in 2019. Its large share can beattributed to technological advancements in this segment and increasing awareness.

The breast ultrasound segment was the largest contributor to the non-ionizing breast imaging technologies market in 2019

Non-ionizing breast imaging technologies comprise breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBU), breast thermography, electric impedance tomography, and optical imaging. The breast ultrasound segment accounted for the largest share of the non-ionizing breast imaging technologies market in 2019 whereas the AWBU segment is estimated to witness the second-highest growth rate during the forecast period. The large share of the breast ultrasound segment can beattributed to the lower risk of exposure to radiation and the benefits offered by breast ultrasound such as the ability to detect lesions and the nature of lesions in women with dense breast tissues, the ability to differentiate between a cyst and a solid mass, and the detection of blood flow through vessels.

Asia Pacific is expected to grow at the highest CAGR in the breast imaging market during the forecast period

The Asia Pacific is one of the major revenue-generating regions in the global market. The rising prevalence of breast cancer, increasing healthcare expenditure, increasing number of awareness programs for the early detection of breast cancer, and the high government spending on breast cancer research studies in several APAC countries are the major factors driving the growth of the global market in Asia Pacific. As per GLOBOCAN 2018, a total of 911,014 new breast cancer cases were diagnosed in Asia in 2018, and the number is expected to increase by 229,650 by 2030.

Breast Imaging Market

Key players operating in the global breast imaging market are Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (US), Allengers (India), Dilon Technologies, Inc. (US), Planmed Oy (Finland), Delphinus Medical Technologies, Inc. (US), Micrima Limited (UK), CMR Naviscan Corporation (US), SuperSonic Imagine (France), and Carestream Health (US), among others.

An analysis of the market developments between 2017 and 2020 revealed that several growth strategies such as product launches and enhancements, partnerships, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the global market. Among these business strategies, product approval and launches, acquisition, partnerships and agreements were the most widely adopted growth strategies by market players.

Hologic, Inc.holds the leading position in the breast imaging market, owing to its robust portfolio of breast imaging products and related accessories. Hologic has expanded its product portfolio through insight-driven innovation and strategic M&A to address to establish its position in the market. For instance, during the last three years, Hologic launched several systems and software, such as the Unifi Analytics (November 2019), the new Viera portable breast ultrasound system (February 2018), Brevera Breast Biopsy System with CorLumina Imaging Technology (January 2018), and 3Dimensions Mammography System in Europe (September 2017).

Breast Imaging Market Report Scope:

Report Metric	Details
Market Size Available for Years	2018–2025
Base Year Considered	2019
Forecast Period	2020–2025
Forecast Units	Value (USD)
Segments Covered	Technology, End user, and Region
Geographies Covered	North America (US & Canada), Europe (Germany, France, UK, Italy, Spain, and RoE), APAC (Japan, China, India, Australia, South Korea, and RoAPAC), Latin America (Brazil, Mexico, and, RoLA),and Middle East & Africa
Companies Covered	Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (US), Allengers (India), Dilon Technologies, Inc. (US), Planmed Oy (Finland), Delphinus Medical Technologies, Inc. (US), Micrima Limited (UK), CMR Naviscan Corporation (US), SuperSonic Imagine (France), and Carestream Health (US).Major 15 players covered.

This research report categorizes the breast imaging market into following segments and sub-segments:

By Technology

Ionizing Breast Imaging
- Mammography
  - Full-field Digital Mammography (FFDM)
  - 3D Breast Tomosynthesis
  - Analog Mammography
- Positron Emission Tomography-Computed Tomography (PET-CT)
- Molecular Breast Imaging (MBI)
- Positron Emission Mammography (PEM)
- Cone-beam Computed Tomography (CBCT)
Non-ionizing Breast Imaging
- Breast Ultrasound
- Breast MRI
- Automated Whole-breast Ultrasound (AWBU)
- Breast thermography
- Electric Impedance Tomography
- Optical Imaging

By Region

North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- RoAPAC
Latin America
- Brazil
- Mexico
- RoLA
Middle East & Africa

Key Questions Addressed by the Report:

What are the growth opportunities related to the adoption of breast imaging across major regions in the future?
Emerging countries have immense opportunities for the growth and adoption of breast imaging modalities.
Will this scenario continue in the next five years?
Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
Which are the key end user adoption breast imaging technologies over the forecast period?
What are the new trends and advancements in the breast imaging market? Are there any new modalities being developed for breast cancer screening?

Frequently Asked Questions (FAQ):

What is the expected addressable market value of major breast imaging equipment over a 5-year period?

The global breast imaging market is estimated to be valued at USD 3,649.0 million in 2020 and register a CAGR of 8.1% during the forecast period.

Which technology type is expected to garner highest traction within the breast imaging market?

Breast imaging technologies comprise both ionizing and non-ionizing breast imaging modalities utilized for screening and diagnosis of cancer and other breast-related diseases. The commonly used imaging modalities include mammography, ultrasonography, magnetic resonance imaging (MRI), positron emission tomography (PET), and molecular breast imaging (MBI). The ionizing breast imaging technologies accounted for the largest share of the breast imaging market in 2019. The significant share of the segment is attributed to the surge in the incidences of breast cancer, growing awareness about the early screening and diagnosis of breast cancer, technological advancements, and favorable reimbursement scenario in developed nations.

What are the major factors expected to limit the growth of the breast imaging market?

High price associated with breast imaging systems, stringent regulatory approval process, and side effects associated with radiation exposure are some of the major factors liming the growth of the market.

What are the major revenue pockets in the breast imaging market currently?

The Asia Pacific (APAC) market is expected to record the highest CAGR during the forecast period. Growth of the regional market can primarily be attributed to factors such as rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, and high government spending on breast cancer research studies and to create awareness about the early detection of breast cancer.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 20)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 24)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Breakdown of primaries
                    2.1.2.2 Key data from primary sources
    2.2 MARKET SIZE ESTIMATION
           2.2.1 PRODUCT-BASED MARKET ESTIMATION
           2.2.2 END USER-BASED MARKET SIZE ESTIMATION
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.4 RESEARCH LIMITATIONS AND ASSUMPTIONS
           2.4.1 ASSUMPTIONS FOR THE STUDY
    2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 35)

4 PREMIUM INSIGHTS (Page No. - 39)
    4.1 BREAST IMAGING: MARKET OVERVIEW
    4.2 GEOGRAPHIC ANALYSIS: BREAST IMAGING MARKET, BY TECHNOLOGY AND REGION
    4.3 GEOGRAPHIC ANALYSIS: MAMMOGRAPHY MARKET, BY TYPE AND REGION
    4.4 NON-IONIZING BREAST IMAGING MARKET, BY TYPE AND REGION
    4.5 IONIZING BREAST IMAGING MARKET, BY END USER AND REGION
    4.6 GEOGRAPHIC SNAPSHOT OF THE BREAST IMAGING MARKET

5 MARKET OVERVIEW (Page No. - 45)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Growing incidence of breast cancer
                    5.2.1.2 Increasing public–private investments, funding, and grants
                    5.2.1.3 Growing awareness regarding early detection of breast cancer
                    5.2.1.4 Technological advancements in breast imaging modalities
                    5.2.1.5 Growing aging population
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of breast imaging systems
                    5.2.2.2 Stringent regulatory approval procedures
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging economies offer high growth potential
                    5.2.3.2 Contract-based diagnostic solutions and mobile solutions
           5.2.4 CHALLENGES
                    5.2.4.1 Side effects of radiation exposure
                    5.2.4.2 Errors in breast cancer screening and diagnosis
                    5.2.4.3 Increasing adoption of refurbished imaging systems
    5.3 MARKET TRENDS
           5.3.1 ARTIFICIAL INTELLIGENCE
           5.3.2 PERSONALIZED APPROACH TO BREAST CANCER SCREENING
           5.3.3 MULTIMODAL BREAST IMAGING
    5.4 SCREENING GUIDELINES FOR BREAST CANCER

6 BREAST IMAGING MARKET, BY TECHNOLOGY (Page No. - 57)
    6.1 INTRODUCTION
    6.2 IONIZING BREAST IMAGING TECHNOLOGIES
           6.2.1 MAMMOGRAPHY
                    6.2.1.1 Full-Field Digital Mammography (FFDM)
                               6.2.1.1.1 FFDM offers significant advantages over conventional analog mammography, such as the use of lower radiation doses and reduced breast compression pressure
                    6.2.1.2 Analog mammography
                               6.2.1.2.1 Superior accuracy and efficiency offered by digital mammography have limited the adoption of analog mammography
                    6.2.1.3 3D breast tomosynthesis
                               6.2.1.3.1 The segment to witness the highest growth rate in the mammography market during the forecast period
           6.2.2 POSITRON EMISSION MAMMOGRAPHY (PEM)
                    6.2.2.1 PEM involves radiation exposure throughout the body, which increases the risk of cancer - a major disadvantage associated with this technique
           6.2.3 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT)
                    6.2.3.1 Combined scans from PET and CT offer more accurate results as compared to the individual scans
           6.2.4 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING (MBI/BSGI)
                    6.2.4.1 MBI technique is simple, fast, and highly sensitive
           6.2.5 CONE-BEAM COMPUTED TOMOGRAPHY (CBCT)
                    6.2.5.1 CBCT is the latest among the long history of breast imaging techniques
    6.3 NON-IONIZING BREAST IMAGING TECHNOLOGIES
           6.3.1 BREAST ULTRASOUND
                    6.3.1.1 Low cost, growing awareness, and easy availability of ultrasound devices for breast imaging are driving the growth of this market
           6.3.2 BREAST MRI
                    6.3.2.1 Technological advancements in breast MRI to drive the growth of this segment
           6.3.3 AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU)
                    6.3.3.1 AWBU helps spot small cancers in the mammogram of dense breast
           6.3.4 BREAST THERMOGRAPHY
                    6.3.4.1 The technique is approved by FDA as 'adjunctive tool' to be used alongside with mammography
           6.3.5 ELECTRIC IMPEDANCE TOMOGRAPHY
                    6.3.5.1 Metabolic process related information provided by this technology helps healthcare specialists to select the treatment strategy
           6.3.6 OPTICAL IMAGING
                    6.3.6.1 Advantages associated with the technology, such as high sensitivity, easy accessibility, and lower cost to support the segment growth

7 BREAST IMAGING MARKET, BY END USER (Page No. - 101)
    7.1 INTRODUCTION
    7.2 HOSPITALS & CLINICS
           7.2.1 LARGE HOSPITALS HAVE BEEN EARLY ADOPTERS OF ADVANCED BREAST IMAGING SYSTEMS
    7.3 DIAGNOSTIC IMAGING CENTERS
           7.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS IS CONTRIBUTING TO THE MARKET GROWTH
    7.4 BREAST CARE CENTERS
           7.4.1 INCREASING INCLINATION TOWARD BREAST CARE CENTERS HAS BEEN OBSERVED IN DEVELOPED COUNTRIES
    7.5 OTHER END USERS
           7.5.1 INCREASING RESEARCH ACTIVITIES IS SUPPORTING GROWTH OF THE SEGMENT

8 BREAST IMAGING MARKET, BY REGION (Page No. - 107)
    8.1 INTRODUCTION
    8.2 NORTH AMERICA
           8.2.1 US
                    8.2.1.1 US dominated the North America arket
           8.2.2 CANADA
                    8.2.2.1 Surge in the incidence of breast cancer and favorable government guidelines to support the market growth
    8.3 EUROPE
           8.3.1 GERMANY
                    8.3.1.1 Wide acceptance for both ionizing and non-ionizing imaging technologies in the country
           8.3.2 FRANCE
                    8.3.2.1 Growing initiatives by government and modernization of healthcare infrastructure fueling the demand for breast imaging equipment
           8.3.3 UK
                    8.3.3.1 Initiatives by public & private organizations to increase awareness about breast cancer
           8.3.4 ITALY
                    8.3.4.1 Evolving regulatory scenario for breast imaging and rising incidence of cancer are the major driving factors
           8.3.5 SPAIN
                    8.3.5.1 Growing geriatric population major factor for the market growth
           8.3.6 REST OF EUROPE
    8.4 ASIA PACIFIC
           8.4.1 JAPAN
                    8.4.1.1 Presence of universal healthcare reimbursement scenario and rising breast cancer cases
           8.4.2 CHINA
                    8.4.2.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth
           8.4.3 INDIA
                    8.4.3.1 Government initiatives to improve female health to drive market growth in India
           8.4.4 AUSTRALIA
                    8.4.4.1 Rising research investments and awareness campaigns are the key factors supporting market growth
           8.4.5 SOUTH KOREA
                    8.4.5.1 Supportive government initiatives in the country expected to positively impact market growth
           8.4.6 REST OF APAC
    8.5 LATIN AMERICA
           8.5.1 BRAZIL
                    8.5.1.1 Key market in Latin America owing to the modernization of healthcare facilities
           8.5.2 MEXICO
                    8.5.2.1 Availability of advanced care and increasing awareness programs are fueling the market growth
           8.5.3 REST OF LA
    8.6 MIDDLE EAST & AFRICA
           8.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC–PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA REGION

9 COMPETITIVE LANDSCAPE (Page No. - 160)
    9.1 OVERVIEW
    9.2 MARKET SHARE ANALYSIS
    9.3 COMPETITIVE SCENARIO
           9.3.1 PRODUCT LAUNCHES AND APPROVALS
           9.3.2 ACQUISITIONS
           9.3.3 PARTNERSHIPS AND AGREEMENTS
    9.4 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
           9.4.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2018)
           9.4.2 VISIONARY LEADERS
           9.4.3 INNOVATORS
           9.4.4 DYNAMIC DIFFERENTIATORS
           9.4.5 EMERGING COMPANIES
    9.5 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2019)
           9.5.1 PROGRESSIVE COMPANIES
           9.5.2 STARTING BLOCKS
           9.5.3 RESPONSIVE COMPANIES
           9.5.4 DYNAMIC COMPANIES

10 COMPANY PROFILES (Page No. - 168)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     10.1 HOLOGIC, INC.
     10.2 GE HEALTHCARE (A PART OF GENERAL ELECTRIC COMPANY)
     10.3 SIEMENS HEALTHCARE (A PART OF SIEMENS AG)
     10.4 KONINKLIJKE PHILIPS N.V.
     10.5 FUJIFILM HOLDINGS CORPORATION
     10.6 CANON INC.
     10.7 AURORA HEALTHCARE US CORP.
     10.8 ALLENGERS
     10.9 DILON TECHNOLOGIES, INC.
     10.10 PLANMED OY
     10.11 DELPHINUS MEDICAL TECHNOLOGIES, INC.
     10.12 MICRIMA LIMITED
     10.13 CMR NAVISCAN
     10.14 SUPERSONIC IMAGINE
     10.15 CARESTREAM HEALTH
     10.16 OTHER COMPANIES
             10.16.1 KUB TECHNOLOGIES
             10.16.2 CURA HEALTHCARE
             10.16.3 SONOCINÉ
             10.16.4 NP JSC AMICO
             10.16.5 QT ULTRASOUND LLC

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

11 APPENDIX (Page No. - 205)
     11.1 DISCUSSION GUIDE
     11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.3 AVAILABLE CUSTOMIZATIONS
     11.4 RELATED REPORTS
     11.5 AUTHOR DETAILS

LIST OF TABLES (192 Tables)

TABLE 1 PRIMARY BREAST CANCER SCREENING MODALITIES IN CANADA
TABLE 2 BREAST IMAGING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 3 IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4 MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 5 MAMMOGRAPHY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 NORTH AMERICA: MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 EUROPE: MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 ASIA PACIFIC: MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 LATIN AMERICA: MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 MAMMOGRAPHY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 11 FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 NORTH AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 EUROPE: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 ASIA PACIFIC: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 LATIN AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 17 ANALOG MAMMOGRAPHY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 NORTH AMERICA: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 EUROPE: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 ASIA PACIFIC: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 LATIN AMERICA: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 ANALOG MAMMOGRAPHY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 23 3D BREAST TOMOSYNTHESIS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 EUROPE: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 ASIA PACIFIC: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 LATIN AMERICA: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 3D BREAST TOMOSYNTHESIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 29 POSITRON EMISSION MAMMOGRAPHY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 NORTH AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 EUROPE: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 ASIA PACIFIC: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 LATIN AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 POSITRON EMISSION MAMMOGRAPHY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 35 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 EUROPE: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 ASIA PACIFIC: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 LATIN AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 41 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 EUROPE: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 ASIA PACIFIC: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 LATIN AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 47 CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 48 NORTH AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 ASIA PACIFIC: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 LATIN AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 53 NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 BREAST ULTRASOUND MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: BREAST ULTRASOUND MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: BREAST ULTRASOUND MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 57 ASIA PACIFIC: BREAST ULTRASOUND MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 58 LATIN AMERICA: BREAST ULTRASOUND MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 BREAST ULTRASOUND MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 60 BREAST MRI MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 61 NORTH AMERICA: BREAST MRI MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: BREAST MRI MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 ASIA PACIFIC: BREAST MRI MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 64 LATIN AMERICA: BREAST MRI MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 BREAST MRI MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 66 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 67 NORTH AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 69 ASIA PACIFIC: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 70 LATIN AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 72 BREAST THERMOGRAPHY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 73 NORTH AMERICA: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 EUROPE: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 ASIA PACIFIC: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 LATIN AMERICA: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 BREAST THERMOGRAPHY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 78 ELECTRIC IMPEDANCE TOMOGRAPHY, BY REGION, 2018–2025 (USD MILLION)
TABLE 79 NORTH AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 80 EUROPE: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 81 ASIA PACIFIC: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 82 LATIN AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 84 OPTICAL IMAGING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 85 NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 86 EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 89 OPTICAL IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 90 GLOBAL MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 91 HOSPITALS & CLINICS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 92 DIAGNOSTIC IMAGING CENTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 93 BREAST CENTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 94 OTHER END USERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 95 GLOBAL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 96 NORTH AMERICA: BREAST IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 97 NORTH AMERICA: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 98 NORTH AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 NORTH AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 NORTH AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 NORTH AMERICA: BREAST IMAGING TECHNOLOGIES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 102 US: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 103 US: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 US: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 US: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 CANADA: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 107 CANADA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 CANADA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 CANADA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 EUROPE: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 112 EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 EUROPE: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 EUROPE: BREAST IMAGING TECHNOLOGIES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 116 GERMANY: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 117 GERMANY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 GERMANY: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 GERMANY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 FRANCE: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 121 FRANCE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 FRANCE: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 FRANCE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 UK: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 125 UK: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 UK: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 UK: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 ITALY: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 129 ITALY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 ITALY: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 ITALY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 132 SPAIN: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 133 SPAIN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 SPAIN: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 SPAIN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 REST OF EUROPE: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 137 REST OF EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 REST OF EUROPE: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 REST OF EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 ASIA PACIFIC: BREAST IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 141 ASIA PACIFIC: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 142 ASIA PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 ASIA PACIFIC: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 ASIA PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 ASIA PACIFIC: BREAST IMAGING TECHNOLOGIES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 146 JAPAN: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 147 JAPAN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 JAPAN: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 149 JAPAN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 CHINA: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 151 CHINA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 CHINA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 CHINA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 INDIA: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 155 INDIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 156 INDIA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 INDIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 158 AUSTRALIA: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 159 AUSTRALIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 AUSTRALIA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 161 AUSTRALIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 SOUTH KOREA: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 163 SOUTH KOREA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 SOUTH KOREA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 SOUTH KOREA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 166 REST OF APAC: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 167 REST OF APAC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 168 REST OF APAC: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 REST OF APAC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170 LATIN AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 171 LATIN AMERICA: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 172 LATIN AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 LATIN AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 LATIN AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 175 LATIN AMERICA: BREAST IMAGING TECHNOLOGIES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 176 BRAZIL: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 177 BRAZIL: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 178 BRAZIL: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 179 BRAZIL: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 MEXICO: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 181 MEXICO: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 182 MEXICO: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183 MEXICO: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 184 REST OF LA: BREAST IMAGING MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 185 REST OF LA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 186 REST OF LA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 187 REST OF LA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 MIDDLE EAST AND AFRICA: MARKET SIZE, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 189 MIDDLE EAST AND AFRICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 MIDDLE EAST AND AFRICA: MAMMOGRAPHY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 191 MIDDLE EAST AND AFRICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 192 MIDDLE EAST AND AFRICA: BREAST IMAGING TECHNOLOGIES MARKET, BY END USER, 2018–2025 (USD MILLION)

LIST OF FIGURES (32 Figures)

FIGURE 1 BREAST IMAGING MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 GLOBAL MARKET VALUE, BY TECHNOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 8 IONIZING BREAST IMAGING MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 9 NON-IONIZING BREAST IMAGING MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 10 GLOBAL MARKET SHARE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 11 GEOGRAPHIC SNAPSHOT OF THE GLOBAL MARKET
FIGURE 12 INCREASING PREVALENCE OF BREAST CANCER IS DRIVING THE GROWTH OF GLOBAL MARKET ACROSS THE GLOBE
FIGURE 13 NON-IONIZING BREAST IMAGING TECHNOLOGY SEGMENT WILL WITNESS HIGH GROWTH IN THE MARKET IN 2025
FIGURE 14 FULL-FIELD DIGITAL MAMMOGRAPHY SEGMENT TO DOMINATE THE ASIA PACIFIC MAMMOGRAPHY MARKET IN 2020
FIGURE 15 BREAST ULTRASOUND TO REGISTER SIGNIFICANT GROWTH IN THE LATIN AMERICA NON-IONIZING BREAST IMAGING MARKET
FIGURE 16 HOSPITALS & CLINICS ARE THE KEY END USERS, WHILE THE BREAST CARE CENTERS TO REGISTER SUBSTANTIAL GROWTH IN THE EUROPEAN MARKET
FIGURE 17 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 18 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 19 NUMBER OF BREAST CANCER CASES IN 2018, BY KEY COUNTRIES
FIGURE 20 NORTH AMERICA: BREAST IMAGING MARKET SNAPSHOT
FIGURE 21 ASIA PACIFIC: BREAST IMAGING MARKET SNAPSHOT
FIGURE 22 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO 2020
FIGURE 23 GLOBAL BREAST IMAGING MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 24 BREAST IMAGING MARKET (GLOBAL) COMEPITIVE LEADERSHIP MAPPING, 2019 (OVERALL MARKET)
FIGURE 25 BREAST IMAGING MARKET (GLOBAL) COMEPITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)
FIGURE 26 HOLOGIC, INC.: COMPANY SNAPSHOT
FIGURE 27 GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 28 SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT
FIGURE 29 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 30 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
FIGURE 31 CANON INC.: COMPANY SNAPSHOT
FIGURE 32 SUPERSONIC IMAGINE: COMPANY SNAPSHOT

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the breast imaging market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the breast imaging market scenario through secondary research. A significant number of primary interviews were conducted from both the demand (fiducial marker suppliers, vendors, and distributors, personnel from hospitals & clinics, cancer research laboratories, and radiology centers) and supply sides (presidents, CEOs, vice presidents, directors, general managers, heads of business segments, and senior managers). The primaries interviewed for this study include experts from the breast imaging industry, such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering breast imaging across the globe; administrators and purchase managers; and academic research institutes.

A breakdown of the primary respondents is provided below:

Breast Imaging Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by technology, end user, and region).

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the breast imaging industry.

Report Objectives:

To define, describe, and forecast the breast imaging market by type of technology, end user, and region
To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze micromarkets with respect to their individual growth trends, prospects, and contributions to the total market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the revenue of market segments with respect to four regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and LoLA), and the Middle East & Africa
To strategically profile the key players and comprehensively analyze their market shares and core competencies
To track and analyze competitive developments such as product launches and product enhancements; agreements, partnerships, and collaborations; acquisitions; and R&D developments in the breast imaging market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global breast imaging market report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Geographic Analysis

Further breakdown of the Rest of Europebreast imaging market into Belgium, Austria, the Czech Republic, Denmark, Greece, Poland, and Russia, among other
Further breakdown of the Rest of Asia Pacific breast imaging market into wan, New Zealand, Vietnam, the Philippines, Singapore, Malaysia, Thailand, and Indonesiaamong other
Further breakdown of the Latin American breast imaging market into Argentina, Chile, Peru, and Colombia, among other

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.